OncoAlert and ecancer weekly roundup for January 25 - 31, 2021
OncoAlert and ecancer weekly roundup for January 25 - 31, 2021
Role of PARP inhibitors in treating advanced prostate cancer
Highlights from BGICC 2021
Escalation and descalation in neoadjuvant time to treatment of TNBC
WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC
A new way of thinking on the origin of breast cancer and how early breast cancer should be treated
Recent therapies for HER2 advanced breast cancer
Emerging treatments for relapsed/refractory Hodgkin’s lymphoma in China
BRCA mutation in metastatic TNBC patients
The role of immune checkpoint inhibitors in NSCLC
Challenges in oncology management during the COVID-19 era
OncoAlert and ecancer weekly roundup for January 18 - 24, 2021